Expertise in
39
conditions

Dr. Faithlore P. Gardner

Hematology | Oncology
Florida Cancer Specialists And Research Institute
1708 Cape Coral Pkwy W Ste 10, 
Cape Coral, FL 
Accepting New Patients
Offers Telehealth
Expertise in
39
conditions
Florida Cancer Specialists And Research Institute
1708 Cape Coral Pkwy W Ste 10, 
Cape Coral, FL 

Overview

Faithlore Gardner is a Hematologist and an Oncologist practicing medicine in Cape Coral, Florida.

Dr. Gardner is highly rated in 39 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Anemia.

Dr. Gardner is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 5 clinical trials. Dr. Gardner is currently accepting new patients.

Graduate Institution

University Of South Florida College Of Medicine

Residency

Vanderbilt University Hospital , Internal Medicine

Specialties

Hematology
Oncology

Licenses

Internal Medicine in FL

Board Certifications

American Board Of Internal Medicine

Fellowships

Mayo Clinic - Jacksonville , Internal Medicine

Hospital Affiliations

Cape Coral Hospital
Cape Coral Hospital
Gulf Coast Medical Center Lee Health
Lee Memorial Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Florida Cancer Specialists And Research Institute
1708 Cape Coral Pkwy W Ste 10, Cape Coral, FL 33914
Other Locations
Florida Cancer Specialists Pl
1708 Cape Coral Pkwy W Ste 10, Cape Coral, FL 33914
Florida Cancer Specialists Pl
1030 Commerce Creek Blvd, Cape Coral, FL 33909

Additional Areas of Focus

Dr. Gardner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation
Enrollment Status: Terminated
Publish Date: July 14, 2026
Intervention Type: Drug
Study Drugs: alpelisib, nab-paclitaxel
Study Phase: Phase 3
A Phase 2 Study of Avutometinib (VS-6766) (Dual RAF/MEK Inhibitor) as a Single Agent and In Combination With Defactinib (FAK Inhibitor) in Recurrent KRAS-Mutant (KRAS-MT) and BRAF-Mutant (BRAF-MT) Non-Small Cell Lung Cancer (NSCLC) (RAMP 202)
A Phase 2 Study of Avutometinib (VS-6766) (Dual RAF/MEK Inhibitor) as a Single Agent and In Combination With Defactinib (FAK Inhibitor) in Recurrent KRAS-Mutant (KRAS-MT) and BRAF-Mutant (BRAF-MT) Non-Small Cell Lung Cancer (NSCLC) (RAMP 202)
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Drug
Study Drugs: VS-6766, VS-6766+Defactinib
Study Phase: Phase 2
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Drugs: Olaratumab, Nab-paclitaxel, Gemcitabine
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

7 Total Publications

Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.
Phase 3 PERSPECTIVE study: Ibrutinib with rituximab for initial treatment of patients with follicular lymphoma.
Journal: HemaSphere
Published: September 17, 2025
Similar Doctors
Expertise in
32
conditions
Dr. Lowell L. Hart
Hematology | Oncology
Expertise in
32
conditions
Dr. Lowell L. Hart
Hematology | Oncology
Referral may be required

Florida Cancer Specialists Pl

8260 Gladiolus Dr, 
Fort Myers, FL 
 (7.8 miles away)
239-437-5755
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Lowell Hart is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Hart is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, Paget Disease of the Breast, and Familial Colorectal Cancer. Dr. Hart is board certified in American Board Of Internal Medicine. Dr. Hart is currently accepting new patients.

Expertise in
21
conditions
Dr. William N. Harwin
Hematology | Oncology
Expertise in
21
conditions
Dr. William N. Harwin
Hematology | Oncology
Referral may be required

Florida Cancer Specialists P L

15681 New Hampshire Ct, 
Fort Myers, FL 
 (7.7 miles away)
239-437-4444
Languages Spoken:
English
See accepted insurances

William Harwin is a Hematologist and an Oncologist practicing medicine in Fort Myers, Florida. Dr. Harwin is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Clear Cell Sarcoma.

Expertise in
32
conditions
Dr. Silvia A. Romero
Hematology | Oncology
Expertise in
32
conditions
Dr. Silvia A. Romero
Hematology | Oncology
Referral may be required

Florida Cancer Specialists Pl

1708 Cape Coral Pkwy W Ste 10, 
Cape Coral, FL 
 (0.1 miles away)
239-541-4633
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Silvia Romero is a Hematologist and an Oncologist practicing medicine in Cape Coral, Florida. Dr. Romero is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Angiosarcoma. Dr. Romero is board certified in American Board Of Internal Medicine. Dr. Romero is currently accepting new patients.

Frequently Asked Questions about Dr. Faithlore P. Gardner

How do I make an appointment with Dr. Faithlore P. Gardner?

You can book an appointment with Dr. Faithlore P. Gardner by calling their office at 239-541-4633. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Faithlore P. Gardner a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Faithlore P. Gardner is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Faithlore P. Gardner specialize in?

While Dr. Faithlore P. Gardner is a Hematology, they have specific expertise in Paget Disease of the Breast, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Faithlore P. Gardner participate in research or clinical trials?

Yes. Dr. Faithlore P. Gardner has published 7 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Faithlore P. Gardner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Faithlore P. Gardner accept my insurance?

Dr. Faithlore P. Gardner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 239-541-4633 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gardner's expertise for a condition
ConditionClose
    View All 35 Advanced Conditions
    View All 82 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile